Post Profile






Gold nanostars and immunotherapy vaccinate mice against cancer

(Duke University) By combining an FDA-approved cancer immunotherapy with an emerging tumor-roasting nanotechnology, Duke researchers improved the efficacy of both therapies in a proof-of-concept study using mice. The potent combination also attacked satellite tumors and distant cancerous cells, completely curing two mice and effectively vaccinating one against the disease.
read more

share

Related Posts


Medical News Today: Cancer drugs that halt tumors can also shrink them

Health : Medical News Today

New research reveals how CDK4/6 inhibitors, approved cancer drugs that halt tumors, can also shrink them in some cases by promoting anti-tumor immunity.

Ludwig researchers show that infecting just 1 tumor with a virus could boost the systemic effectiveness of cancer immunotherapy

Health : Medical News Today

A Ludwig Cancer Research study suggests that the clinical efficacy of checkpoint blockade, a powerful new strategy to harness the immune response to treat cancers, might be dramatically improved if combined with oncolytic virotherap...

Tetanus Shot Improves Patient Survival with Brain Tumor Immunotherapy

Health : Newswise Medical News

An innovative approach using a tetanus booster to prime the immune system enhances the effect of a vaccine therapy for lethal brain tumors, dramatically improving patient survival, according to a study led by Duke Cancer Institute r...

Leading cancer research organizations to host cancer immunotherapy conference

Health : EurekAlert: Health

(American Association for Cancer Research) The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will sponsor the third In...

Gold nanostars and immunotherapy vaccinate mice against cancer

Academics / General Science : Physorg: Nanotechnology

By combining an FDA-approved cancer immunotherapy with an emerging tumor-roasting nanotechnology, Duke University researchers improved the efficacy of both therapies in a proof-of-concept study using mice.

Comments


Copyright © 2016 Regator, LLC